Clin2
NCT06989450Possibly a fitRecruiting

Digital support for women on hormone therapy for breast cancer

Breast CancerCancer

Part of Cancer, Skin clinical trials.

This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and were diagnosed with stage I, II, or III breast cancer on or after September 1, 2023.
  • Your doctor has prescribed hormone therapy (like tamoxifen or an aromatase inhibitor) after surgery.
  • You can read and understand Icelandic or English.
  • You own a smartphone that can run the Sidekick app and are willing to use it for the study.
  • You have not used the Sidekick breast cancer program before.
  • You do not have stage IV (metastatic) breast cancer or other serious health issues that might interfere.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06781996Recruiting· Phase 3
Digital tool to help manage hormone therapy side effects

This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.

Villejuif
NCT06729684Recruiting
Digital health program for breast cancer side effects

This study is testing a personalized digital health program to help breast cancer survivors manage side effects. It uses a smartphone app to track symptoms and offer support.

Seoul, Republic of Korea
NCT07454499Recruiting
Symptom monitoring and health for women on hormone therapy for breast cancer

This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.

Philadelphia, Pennsylvania
NCT06977360Recruiting
Smartphone support for women with breast cancer on chemo

This study tests a new smartphone app designed to help women with breast cancer manage their chemotherapy treatment and its side effects. It aims to see if the app is easy to use and helpful for women going through chemo for the first time.

Singapore
NCT07482384Recruiting
Support program for young women with early-stage breast cancer

This study tests a mobile health program that provides support and information to young women with early-stage breast cancer who are on hormone therapy. The goal is to help you stay on your treatment and manage side effects.

Boston, Massachusetts
NCT07676591Not yet recruiting
EmpowerHer: digital support program for breast cancer survivors

This trial tests a smartphone-based program to help breast cancer survivors with exercise and wellness after finishing active treatment. It aims to improve your recovery and quality of life.

Valencia, Valencia

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.